S. Heylen

775 total citations
11 papers, 560 citations indexed

About

S. Heylen is a scholar working on Psychiatry and Mental health, Pharmacology and Neurology. According to data from OpenAlex, S. Heylen has authored 11 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 3 papers in Pharmacology and 2 papers in Neurology. Recurrent topics in S. Heylen's work include Schizophrenia research and treatment (7 papers), Treatment of Major Depression (3 papers) and Electroconvulsive Therapy Studies (2 papers). S. Heylen is often cited by papers focused on Schizophrenia research and treatment (7 papers), Treatment of Major Depression (3 papers) and Electroconvulsive Therapy Studies (2 papers). S. Heylen collaborates with scholars based in Belgium, France and Portugal. S. Heylen's co-authors include Y Gelders, H. De Cuyper, Marc Eneman, J. Bollen, A. Claus, J. Peuskens, Philip Burton, G. Sieben, Rudi Vermote and Kenneth D. Roose and has published in prestigious journals such as Psychopharmacology, Schizophrenia Research and Acta Psychiatrica Scandinavica.

In The Last Decade

S. Heylen

11 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Heylen Belgium 7 452 99 97 96 94 11 560
Richard M. Steinbook United States 12 346 0.8× 70 0.7× 87 0.9× 84 0.9× 93 1.0× 26 543
A. I. Green United States 8 580 1.3× 114 1.2× 82 0.8× 131 1.4× 152 1.6× 9 718
Bijan Bastani United States 9 445 1.0× 118 1.2× 61 0.6× 139 1.4× 189 2.0× 9 700
Michael H. Kronig United States 10 614 1.4× 51 0.5× 111 1.1× 158 1.6× 138 1.5× 13 743
Philippe Bouhours France 11 329 0.7× 75 0.8× 131 1.4× 88 0.9× 70 0.7× 20 481
Evelyn Howanitz United States 8 465 1.0× 168 1.7× 98 1.0× 148 1.5× 90 1.0× 12 612
Joseph Pultz United States 8 296 0.7× 57 0.6× 85 0.9× 47 0.5× 115 1.2× 11 526
H. A. McClelland United Kingdom 13 300 0.7× 77 0.8× 68 0.7× 60 0.6× 67 0.7× 25 518
Julie Cole United States 12 335 0.7× 51 0.5× 97 1.0× 43 0.4× 102 1.1× 17 611
Umberto Micò Italy 13 347 0.8× 93 0.9× 100 1.0× 61 0.6× 242 2.6× 21 584

Countries citing papers authored by S. Heylen

Since Specialization
Citations

This map shows the geographic impact of S. Heylen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Heylen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Heylen more than expected).

Fields of papers citing papers by S. Heylen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Heylen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Heylen. The network helps show where S. Heylen may publish in the future.

Co-authorship network of co-authors of S. Heylen

This figure shows the co-authorship network connecting the top 25 collaborators of S. Heylen. A scholar is included among the top collaborators of S. Heylen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Heylen. S. Heylen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Verbeke, Geert, et al.. (1997). A patient with unique bilateral ovarian metastases 11 years after the treatment of breast cancer.. PubMed. 97(6). 302–5. 2 indexed citations
2.
Verbeke, Geert, et al.. (1995). A NON-HODGKIN-LYMPHOMA OF THE BREAST, OCCURRING 20 YEARS AFTER THE TREATMENT OF A HODGKINS-DISEASE. Oncology Reports. 2(5). 843–5. 1 indexed citations
3.
Vermote, Rudi, et al.. (1993). Risperidone as add‐on therapy in behavioural disturbances in mental retardation: a double‐blind placebo‐controlled cross‐over study. Acta Psychiatrica Scandinavica. 87(3). 167–171. 86 indexed citations
4.
Wilms, Guy, Chantal Van Ongeval, A. L. Baert, et al.. (1992). Ventricular enlargement, clinical correlates and treatment outcome in chronic schizophrenic inpatients. Acta Psychiatrica Scandinavica. 85(4). 306–312. 19 indexed citations
5.
Heylen, S. & Y Gelders. (1992). RISPERIDONE, A NEW ANTIPSYCHOTIC WITH SEROTONIN 5-HT2 AND DOPAMINE D2 ANTAGONISTIC PROPERTIES.. Clinical Neuropharmacology. 15. 180A–181A. 9 indexed citations
6.
Claus, A., J. Bollen, H. De Cuyper, et al.. (1992). Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double‐blind comparative study. Acta Psychiatrica Scandinavica. 85(4). 295–305. 251 indexed citations
7.
Heylen, S. & Y Gelders. (1990). Combined serotonin 5-HT2 and dopamine D2 receptor antagonism in the treatment of schizophrenia. Schizophrenia Research. 3(1). 46–47. 1 indexed citations
8.
9.
Burton, Philip, et al.. (1989). Therapeutic effect and safety of increasing doses of risperidone (R 64766) in psychotic patients. Psychopharmacology. 99(4). 445–449. 97 indexed citations
10.
Gelders, Y, et al.. (1989). The efficacy of the D2 and 5-HT2 antagonist risperidone (R 64 766) in the treatment of chronic psychosis. Schizophrenia Research. 2(4-5). 411–415. 70 indexed citations
11.
Roose, Kenneth D., Y Gelders, & S. Heylen. (1989). Risperidone (R64 766) in psychotic patients. A first clinical therapeutic exploration.. PubMed. 88(3). 233–41. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard M. Steinbook Breakdown of academic impact, for papers by A. I. Green Breakdown of academic impact, for papers by Bijan Bastani Breakdown of academic impact, for papers by Michael H. Kronig Breakdown of academic impact, for papers by Philippe Bouhours Breakdown of academic impact, for papers by Evelyn Howanitz Breakdown of academic impact, for papers by Joseph Pultz Breakdown of academic impact, for papers by H. A. McClelland Breakdown of academic impact, for papers by Julie Cole Breakdown of academic impact, for papers by Umberto Micò
Rankless by CCL
2026